<!-- received="Tue Oct 12 09:26:40 1999 MST" -->
<!-- sent="Tue, 12 Oct 1999 08:33:48 -0700" -->
<!-- name="J. R. Molloy" -->
<!-- email="jr@shasta.com" -->
<!-- subject="Re: MED/NEURO: Human trials of spinal nerve regeneration in ~1 year?" -->
<!-- id="00f201bf14c7$338eb0a0$8abc473f@j-r-molloy" -->
<!-- inreplyto="MED/NEURO: Human trials of spinal nerve regeneration in ~1 year?" -->
<!-- version=1.10, linesinbody=28 -->
<html><head><title>extropians: Re: MED/NEURO: Human trials of spinal nerve regeneration in ~1 year?</title>
<meta name=author content="J. R. Molloy">
<link rel=author rev=made href="mailto:jr@shasta.com" title ="J. R. Molloy">
</head><body>
<h1>Re: MED/NEURO: Human trials of spinal nerve regeneration in ~1 year?</h1>
J. R. Molloy (<i>jr@shasta.com</i>)<br>
<i>Tue, 12 Oct 1999 08:33:48 -0700</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#705">[ date ]</a><a href="index.html#705">[ thread ]</a><a href="subject.html#705">[ subject ]</a><a href="author.html#705">[ author ]</a>
<!-- next="start" -->
<li><a href="0706.html">[ Next ]</a><a href="0704.html">[ Previous ]</a>
<b>Maybe in reply to:</b> <a href="0705.html">J. R. Molloy</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="0724.html">Robert J. Bradbury</a>
</ul>
<!-- body="start" -->

<p>
From: Brian Manning Delaney &lt;bdelaney@infinitefaculty.org&gt;
<br>
<i>&gt;&gt; Too bad the FDA will probably ditch the</i><br>
<i>&gt;&gt; project in the US.</i><br>
<i>&gt;</i><br>
<i>&gt;Eh? Why would the FDA ditch the project? Anti-Semitism?</i><br>
<i>&gt;(Proneuron is Israeli.) That don't make no sense. The FDA itself</i><br>
<i>&gt;is run by Jews (since it's part of Z.O.G., Zionist Occupation</i><br>
<i>&gt;Government), and is integral in Jewish attempts to increase the</i><br>
<i>&gt;power of the UN, which will soon allow Jewish-run businesses</i><br>
<i>&gt;greater access to foreign markets, Christian babies, etc., etc.,</i><br>
<i>&gt;etc.</i><br>

<p>
<a name="0724qlink1">FDA suspends gene therapy studies
</a>
<p>
WASHINGTON (AP) - The government has ordered Schering-Plough Corp. to
temporarily halt two gene therapy studies because the research is
designed similarly to a Pennsylvania experiment in which a teen-ager
died last month. No one yet knows what killed Jesse Gelsinger, 18, of
Tucson, Ariz. Just four days before his death, University of
<a name="0724qlink2">Pennsylvania scientists had placed healthy genes in his liver to
combat a rare metabolic disease.</a> Penn's study has been halted while
<a name="0724qlink3">scientists there, along with federal regulators, try to determine
what went wrong.</a> The Food and Drug Administration decision late
<a name="0724qlink4">Friday halts two separate experiments by Schering-Plough to try gene
therapy as a treatment for liver cancer and for colorectal cancer
that spreads to the liver. 
</a>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="0706.html">[ Next ]</a><a href="0704.html">[ Previous ]</a>
<b>Maybe in reply to:</b> <a href="0705.html">J. R. Molloy</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="0724.html">Robert J. Bradbury</a>
</ul>
</body></html>
